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Macrophages and dendritic cells (DC) in tissues with close contact to the environment are of essential importance
in host defense and are therefore present in sizeable numbers. Therefore, it is surprising that mononuclear
phagocyte populations of the dermis have rarely been investigated in a quantitative manner. In this study, we
examined mouse dermal skin immunophenotypically and related the observed numbers of observed cells to the
total number of nucleated cells. These analyses show that about 70% of all dermal cells represent CD45þ le-
ukocytes. The vast majority of these cells (60% of total) expresses the mononuclear phagocyte markers mMGL
(ER-MP23), F4/80 and CD11b. In addition, these cells show avid phagocytic capacity and thus are identiﬁed as
dermal macrophages. Different subpopulations can be deﬁned using markers such as sialoadhesin, ER-HR3 and
mSIGN-R1 (ER-TR9). Interestingly, MHC class II expression differs significantly between dermal cells from ear
versus back skin. Moreover, we have identiﬁed small populations of dermal DC and migrating Langerhans cells
(together 10% of total). In summary, our ﬁndings show that mononuclear phagocyte populations form the ma-
jority of dermal cells and thus have been clearly underestimated so far.
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Mononuclear phagocytes, i.e. macrophages and dendritic
cells (DC), are crucial initiators and regulators of both innate
and adaptive host defense responses. As a consequence,
especially tissues in close contact with the environment
possess sizeable populations of mononuclear phagocytes.
In the skin, different populations of such sentinel cells have
been described: in the suprabasal layer of the epidermis,
where Langerhans cells (LC) build up a network with their
dendrites, and in the dermis, where interstitial dermal
dendritic cells and dermal macrophages reside between
extracellular matrix components. Dermal mononuclear
phagocytes appear to be important for skin immunity, as
they are highly competent in inducing an immune response
without involvement of epidermal LC (Streilein, 1989; Allan
et al, 2003). Surprisingly enough, dermal mononuclear
phagocyte populations have never been investigated in a
quantitative manner compared to the total amount of der-
mal cells. Therefore, we performed immunofluorescence
double stainings on mouse ear and back skin sections using
different macrophage and DC markers. To be able to com-
pare the amount of stained cells to the total amount of
dermal cells, we counterstained the sections with DAPI to
identify all nucleated cells. Thereafter, we assessed the
phenotype of 200–400 dermal nucleated cells, excluding
cells in skin appendages.
Results and Discussion
The starting point in our analyses was the reactivity of the
anti-mononuclear phagocyte antibody ER-MP23 (Jansen
et al, 1994; Leenen et al, 1994). This antibody recognizes an
epitope on mMGL (murine macrophage galactose/N-ace-
tylgalactosamine-specific C-type lectin; Oda et al, 1988;
McKnight and Gordon, 1998), also known as DC-ASGPR
(dendritic cell asialoglycoprotein receptor, Valladeau et al,
2001), and has been described previously to label connec-
tive tissue macrophages strongly (Jansen et al, 1994; Lee-
nen et al, 1994). Staining of skin sections for this marker
revealed that a majority of all dermal cells expressed it
(55%  3% in back skin and 58%  4% in ear skin, resp.).
To ascertain that this number did not originate from dermal
fibroblasts expressing mMGL, we performed double stain-
ings for mMGL and CD45, the pan leukocyte marker. As
shown in Fig 1A, all mMGL-positive cells also stained
positively for CD45. In addition, around 14% of all back
dermal cells were single positive for CD45, whereas 31%
expressed neither of both markers. A similar result was ob-
tained in the ear skin dermis.
To analyze further the nature of mMGL-positive cells,
we performed double stainings for mMGL and other ma-
crophage markers: F4/80, CD11b, MOMA-1/sialoadhesin,
ER-HR3, ER-TR9/mSIGN-R1 and MHC class II. The staining
of F4/80 and mMGL virtually coincided (Fig 1B); 63% of all
dermal cells were counted as double positive cells, 1% as
single mMGL-positive cells, 2% single F4/80-positive cells
and 34% as double negative cells in the back dermis.Abbreviations: DC, dendritic cells; LC, Langerhans cells
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CD11b was, as F4/80, expressed on almost all mMGL-
positive cells (Fig S1, online; 55% double positive, 1% sin-
gle mMGL-positive, 4% single CD11b-positive and 40%
double negative cells). The 4% single CD11b-positive cells
presumably represent dermal mast cells. MOMA-1 was
found to bind a subpopulation of dermal phagocytes, in
particular those cells laying deeper in the dermis (Fig S1,
online; 23% double positive, 39% single mMGL-positive,
2% single MOMA-1-positive, 37% double negative). ER-
HR3, with still unknown binding epitope, likewise stained a
significant subpopulation of mMGL-positive cells through-
out the dermis (Fig S1, online; 42% double positive, 18%
single mMGL-positive, 5% single ER-HR3-positive, 35%
double negative). ER-TR9, which recognizes mSIGN-R1
(Kang et al, 2003), has been found to stain a small percent-
age of cells in the dermis (6%–8%; Fig S1, online). For all
these markers, similar numbers have been obtained com-
paring back skin to ear skin dermis. When we compared the
staining of dermal cells of the two sites for MHC class II, we
found that virtually all mMGL-positive cells in the back de-
rmis expressed this marker (58% double positive, 3% single
mMGL-positive, 4% single MHC class II-positive, 35%
double negative; Fig 2A). In marked contrast, only a minor
subpopulation of all mMGL-positive cells expressed MHC
class II in the ear dermis (20% double positive, 40% single
mMGL-positive, 2% single MHC class II-positive, 38%
double negative; Fig 2B). To explain this divergence, we
speculate that differences in the structure of the dermis at
different locations (subdermal adipose tissue vs cartilage)
create different microenvironments that differentially influ-
ence the expression of the MHC class II molecules.
To seek further confirmation regarding the nature of
mMGL-positive dermal cells, we made use of the fact that
macrophages are the only connective tissue cells showing
avid phagocytic capacities. Therefore we injected DiI-labe-
led liposomes, which previously have been shown to target
phagocytic cells exclusively (Buiting et al, 1993), into the ear
Figure 1
The majority of dermal interstitial cells express mononuclear
phagocyte markers. Back skin sections were stained for mMGL / ER-
MP23 (red) and CD45 (green) (A) or mMGL (red) and F4/80 (green) (B).
Sections were counterstained with DAPI, showing nuclei in blue. (A)
About 60% of all dermal cells express mMGL. All mMGL-positive
cells also express CD45. About 10% of the CD45-positive cells are
mMGL-negative. (B) Staining for mMGL and F4/80 virtually coincided.
Note the gradient of increasing F4/80 expression toward the epidermal
side, which could be observed occasionally. Scale bar¼ 50 mm for all
pictures.
Figure2
Dermal macrophages from different sites show differential MHC
class II expression. Back skin sections (A) and ear skin sections (B)
were stained for mMGL (red) and for MHC class II (green). Sections
were counterstained with DAPI. (A) In the back skin, virtually all mMGL-
positive cells coexpress MHC class II. (B) Similar to the back skin, the
ear dermis contains about 60% interstitial cells expressing mMGL.
However, only about one third of these cells coexpresses MHC class II
molecules. These mMGL/MHC class II double-positive cells are ar-
ranged in clusters. Scale bar¼ 50 mm for all pictures.
Figure3
mMGL-positive dermal cells are phagocytic. DiI-labeled liposomes
(red label) were injected into ear dermis. Four hours later, animals were
euthanized, ears cut off, frozen, sectioned, and stained for mMGL
(green). Note that the vast majority, but not all mMGL-positive cells,
have taken up liposomes, whereas mMGL-negative cells and keratino-
cytes remained free of labeling. Scale bar¼50 mm for all pictures.
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dermis. Thereafter we killed the mice, made sections of the
treated ears and stained for mMGL. As shown in Fig 3, we
indeed found that the vast majority of mMGL-positive
cells had taken up DiI-labeled liposomes. However, a few
mMGL-positive cells as well as all mMGL-negative cells re-
mained free of DiI-fluorescence, indicating the specificity of
this procedure. Therefore, we conclude that mMGL-positive
cells not only express mononuclear phagocyte markers but
also possess phagocytic capacity, thus identifying them as
dermal macrophages unequivocally.
To evaluate the presence of DC in the dermis, we stained
back and ear sections for CD11c. To distinguish dermal DC
from migrating LC that are on their way from the epidermis
to skin-draining lymph nodes, we performed a double labe-
ling for Langerin, which specifically stains LC (Valladeau
et al, 2002). As shown in Fig 4, we indeed found a sub-
population of CD11cþ Langerin dermal DC (7%), while
even fewer cells represented migrating LC, which all ex-
pressed CD11c (4% CD11cþ Langerinþ ). DC-SIGN is a
specific marker for dermal DC in the human situation (Turv-
ille et al, 2002). Therefore, we wondered whether ER-TR9
(mSIGN-R1) would recognize dermal DC specifically in the
mouse. Double stainings for ER-TR9 and CD11c revealed
that ER-TR9 recognized a small subset of dermal APC (6%–
8%), but that it did not uniquely stain CD11cþ cells (Fig S1,
online and data not shown).
To summarize, we have shown that mononuclear
phagocytes constitute the major population of nucleated
cells in the mouse dermis where they amount to about 60%
of all dermal cells (Table I). Previous studies have quantified
dermal mononuclear phagocyte subsets for mice (Durai-
swamy et al, 1994) and for humans (Meunier et al, 1993) by
flowcytometric analyses of dermal cell suspensions. In con-
trast to our findings, these authors concluded that dermal
macrophages and dermal DC only composed around 5% of
all dermal cells. The discrepancy between their findings and
ours lies most probably in the difference of the used meth-
ods, as we stained and counted cells in situ in the non-
denaturated dermis. Clearly, during the digestion procedure
needed to obtain a dermal cell suspension, markers either
may have been destroyed by enzymatic digestion, as is
known to happen with the CD1 molecules, or the procedure
may have released fibroblasts preferentially. We further tried
to strengthen our findings by staining and counting fibro-
blasts specifically, but were not successful due to the
unavailability of suitable markers. However, the concept
that most dermal interstitial cells are indeed mononuclear
phagocytes is well supported as we found similar percent-
ages for dermal mononuclear phagocytes using several
markers (F4/80, CD11b, mMGL, CD68 (data not shown) and
MHC class II in the back dermis). Furthermore, this high
frequency is confirmed by the CD45 pan-leukocyte labeling.
Taken together, we feel that the size of the dermal mono-
nuclear phagocyte population has been clearly underesti-
mated so far. These cells probably play crucial roles in skin
inflammatory and immune responses and they should be
taken into account when the role of the dermis is studied in
steady state and inflammatory conditions.
Materials and Methods
Immunofluorescence double stainings on mouse (C57BL/6) ear
and back skin sections have been performed essentially as de-
scribed (Stoitzner et al, 2003). Details can be obtained from the
online supplementary materials.
Figure 4
Dermal DC constitute a small, distinct mononuclear phagocyte
population. Back skin sections were stained for CD11c (red) and La-
ngerin (green) (A) or CD11c (red) and mMGL (green) (B). Sections were
counterstained with DAPI. (A) About 7% of all dermal cells express
CD11c but does not express Langerin. These cells thus represent
genuine DDC (marked with thin arrows). Note that the CD11c staining is
too weak to let CD11c/Langerin-double-positive mLC (marked with
thick arrows) appear yellow. (B) Double staining for CD11c and mMGL
shows that most CD11c-positive cells coexpress mMGL (arrow). Thus,
most if not all DDC express mMGL. The red labeled cell marked with an
asterisk is part of a sebaceous gland and displays autofluorescence
rather than specific labeling. Scale bar¼ 50 mm for all pictures.
Table I. Frequencies of different cell populations in the mouse
dermis, related to total nucleated cells; the quantiﬁcation is
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Supplementary Material
The following material is available from http://www.blackwellpublishing.
com/products/journals/suppmat/JID/JID23427/JID23427sm.htm
Figure S1
Dermal macrophages show different degrees of heterogeneity.
Back skin sections were double-stained for mMGL (red) and other
macrophage markers in green: CD11b (A), MOMA-1 (B), ER-HR3 (C),
mSIGN-R1/ER-TR9 (D). Sections were counterstained with DAPI. (A) All
mMGL-positive cells coexpress CD11b. Separate CD11b single-pos-
itive cells may represent dermal mast cells, or occasional monocytes,
granulocytes or activated Tcells, (B) Staining for MOMA-1 divides DMf
into two subpopulations: cells lying deeper in the dermis express
MOMA-1, whereas cells directly underneath the epidermis do not. (C)
ER-HR3 also divides DMf into two subpopulations, but with no clear
localization pattern. A small number of ER-HR3 single-positive cells
presumably represents mLC. (D) mSIGN-R1/ER-TR9 labels a small
subpopulation of DMf and DDC. The two arrows mark two mMGL/
mSIGN-R1 double-positive cells. Scale bar¼50mm for all pictures.
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